MedTrace Logo

Post Market Study of the InnFocus MicroShunt

NCT02177123 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 107

Last updated 2021-06-24

Study results available
· View outcomes & findings →

Summary

Prospective, multicentric, single arm post market study to gather safety and effectiveness data on the CE Marked InnFocus MicroShunt (MIDI Arrow) device in primary open angle glaucoma patients

Conditions

  • Primary Open Angle Glaucoma

Interventions

DEVICE

InnFocus MicroShunt implantation

Implantation will include the use of Mitomycin C applied with sponges.

Sponsors & Collaborators

  • InnFocus Inc.

    lead INDUSTRY

Principal Investigators

  • Guy Van de Weyer, Optometrist · InnFocus Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-04
Primary Completion
2017-11-27
Completion
2017-11-27

Countries

  • France
  • Netherlands
  • Spain
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02177123 on ClinicalTrials.gov